<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29267612</article-id><article-id pub-id-type="pmc">5731315</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2017-0056</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Analysis of Dyssynchrony and Ventricular Function in Right
Univentricular Stimulation at Different Positions</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Os&#x000f3;rio</surname><given-names>Ana Paula Susin</given-names></name><degrees>MD, MSc</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Warpechowski Neto</surname><given-names>Stefan</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/></contrib><contrib contrib-type="author"><name><surname>Ley</surname><given-names>Antonio Lessa Gaudie</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Miglioranza</surname><given-names>Marcelo Haertel</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ley</surname><given-names>Laura Lessa Gaudie</given-names></name><degrees>LLC</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Almeida</surname><given-names>Eduardo Dytz</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Sant'anna</surname><given-names>Roberto Tofani</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Leiria</surname><given-names>Tiago Luiz Luz</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib></contrib-group><aff id="aff1">
<label>1</label> Programa de P&#x000f3;s-gradua&#x000e7;&#x000e3;o do Instituto de
Cardiologia do Rio Grande do Sul/Funda&#x000e7;&#x000e3;o Universit&#x000e1;ria de
Cardiologia, Porto Alegre, RS, Brazil.</aff><aff id="aff2">
<label>2</label> Pontif&#x000ed;cia Universidade Cat&#x000f3;lica do Rio Grande do Sul
(PUCRS), Porto Alegre, RS, Brazil.</aff><author-notes><corresp id="c1">Correspondence Address: Stefan Warpechowski Neto, Instituto de
Cardiologia do Rio Grande do Sul, Rua Princesa Isabel, 395, Santana - Porto
Alegre, RS, Brazil, Zipcode: 90620-000. E-mail: <email>swneto@gmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Oct-Dec</season><year>2017</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Oct-Dec</season><year>2017</year></pub-date><volume>32</volume><issue>6</issue><fpage>492</fpage><lpage>497</lpage><history><date date-type="received"><day>18</day><month>3</month><year>2017</year></date><date date-type="accepted"><day>08</day><month>6</month><year>2017</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Introduction</title><p>Chronic stimulation of the right ventricle with pacemaker is associated with
ventricular dyssynchrony and loss of contractility, even in subjects without
previous dysfunction. In these patients, there is a debate of which pacing
site is less associated with loss of ventricular function.</p></sec><sec><title>Objective</title><p>To compare pacemaker-induced dyssynchrony among different pacing sites in
right ventricular stimulation.</p></sec><sec><title>Methods</title><p>Cross-sectional study of outpatients with right ventricle stimulation higher
than 80% and preserved left ventricular ejection fraction. Pacing lead
position (apical, medial septum or free wall) was assessed through chest
X-rays. Every patient underwent echocardiogram to evaluate for dyssynchrony
according to CARE-HF criteria: aortic pre-ejection time, interventricular
delay and septum/posterior wall delay on M mode.</p></sec><sec><title>Results</title><p>Forty patients were included. Fifty-two percent had apical electrode
position, 42% mid septum and 6% free wall. Mean QRS time 148.97&#x000b1;15.52
milliseconds. A weak correlation between the mean QRS width and pre-aortic
ejection time (r=0.32; <italic>P</italic>=0.04) was found. No difference in
QRS width among the positions could be noted. Intraventricular delay was
lower in apical patients against mid septal (34.4&#x000b1;17.2
<italic>vs.</italic> 54.3&#x000b1;19.1 <italic>P</italic>&#x0003c;0.05) - no
difference with those electrode on the free wall. No difference was noted in
the pre-aortic ejection time (<italic>P</italic>=0.9).</p></sec><sec><title>Conclusion</title><p>Apical pacing showed a lower interventricular conduction delay when compared
to medial septum site. Our findings suggest that apical pacing dyssynchrony
is not ubiquitous, as previously thought, and that it should remain an
option for lead placement.</p></sec></abstract><kwd-group><kwd>Pacemaker, Artificial</kwd><kwd>Ventricular Dysfunction</kwd><kwd>Heart Failure</kwd><kwd>Stroke Volume</kwd></kwd-group></article-meta></front><body><table-wrap id="t3" orientation="portrait" position="anchor"><table frame="hsides" rules="groups" style="background-color:#e6e7e8"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Abbreviations, acronyms &#x00026; symbols</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">ACE</td><td align="left" rowspan="1" colspan="1">= Angiotensin enzyme converter</td></tr><tr><td align="left" rowspan="1" colspan="1">AF</td><td align="left" rowspan="1" colspan="1">= Atrial fibrillation</td></tr><tr><td align="left" rowspan="1" colspan="1">CAD</td><td align="left" rowspan="1" colspan="1">= Coronary artery disease</td></tr><tr><td align="left" rowspan="1" colspan="1">DM</td><td align="left" rowspan="1" colspan="1">= Diabetes mellitus</td></tr><tr><td align="left" rowspan="1" colspan="1">ECG</td><td align="left" rowspan="1" colspan="1">= Electrocardiography</td></tr><tr><td align="left" rowspan="1" colspan="1">HF</td><td align="left" rowspan="1" colspan="1">= Heart failure</td></tr><tr><td align="left" rowspan="1" colspan="1">LVEF</td><td align="left" rowspan="1" colspan="1">= Left ventricular ejection fraction</td></tr><tr><td align="left" rowspan="1" colspan="1">NYHA</td><td align="left" rowspan="1" colspan="1">= New York Heart Association</td></tr><tr><td align="left" rowspan="1" colspan="1">RV</td><td align="left" rowspan="1" colspan="1">= Right ventricle</td></tr><tr><td align="left" rowspan="1" colspan="1">RVFW</td><td align="left" rowspan="1" colspan="1">= Right ventricle free wall</td></tr><tr><td align="left" rowspan="1" colspan="1">RVMS</td><td align="left" rowspan="1" colspan="1">= Right ventricle medium septum</td></tr><tr><td align="left" rowspan="1" colspan="1">RVOT</td><td align="left" rowspan="1" colspan="1">= Right ventricle outflow tract</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Apical pacing of the right ventricle (RV) has been the preferred site for pacemaker
lead positioning<sup>[<xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>]</sup>. However, data on long-term follow-up revealed
potentially harmful effects of chronic RV apical stimulation<sup>[<xref rid="r3" ref-type="bibr">3</xref>-<xref rid="r5" ref-type="bibr">5</xref>]</sup>. The mechanisms involved in such effects include myofibrillar
derangement and intraventricular and interventricular dyssynchrony, which may lead
to loss of contractile function<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>.
The clinical consequence of such changes manifest through worsening of left
ventricular ejection fraction (LVEF) and, in some cases, heart failure (HF)
symptoms. Once LVEF starts to fall, it leads to deterioration in quality of life, to
an increase in atrial fibrillation burden and to a tendency to a higher
mortality<sup>[<xref rid="r7" ref-type="bibr">7</xref>-<xref rid="r11" ref-type="bibr">11</xref>]</sup>. The DAVID trial<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup> showed that RV pacing is poorly tolerated by
patients and may cause heart failure. The BLOCK-HF<sup>[<xref rid="r13" ref-type="bibr">13</xref>]</sup> study showed that apical RV stimulation
associates with poor outcomes in patients with atrioventricular block and mild to
moderate HF.</p><p>Recent studies suggest that non-apical pacing sites may reduce dyssynchrony and
consequently preserve LVEF<sup>[<xref rid="r14" ref-type="bibr">14</xref>]</sup>.
However, these studies were limited by a relatively small sample size and
heterogeneity of both the selected population and of the methods used for monitoring
for LV function<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>. As such, the
ideal pacing site for patients requiring RV-only pacing, if existent, remains a
matter for debate<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup>.</p><p>In this study, LVEF and ventricular synchrony criteria were compared (as adopted in
the CARE-HF trial)<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup> in patients
with different RV pacing sites.</p></sec><sec sec-type="methods"><title>METHODS</title><p>This was a cross-sectional study conducted at the pacemaker clinic of our institution
between June and November 2015. Patients aged 18 years or older were eligible if
they had a RV pacing percentage above 80 and a LVEF above 50%. Exclusion criteria
were: atrial fibrillation (AF), New York Heart Association (NYHA) HF symptoms class
III our IV, moderate to severe valvular disease, epicardial electrode, biventricular
pacemaker and HF hospitalization before pacemaker implant. All participants signed
the consent form. Study protocol was approved by local ethics committee.</p><p>During the index visit, clinical data and current medication use were assessed.
Clinical data collected were the reason for pacemaker implant, pacemaker program
mode, RV pacing percentage, height, weight, resting heart rate (HR), NYHA HF
functional class status and the presence of comorbidities such as hypertension,
diabetes mellitus (DM), coronary artery disease (CAD), dyslipidemia and smoking
status. Relevant medications assessed were diuretics, angiotensin enzyme converter
(ACE) inhibitors, beta-blockers, calcium channel blockers and amiodarone.</p><p>All patients underwent 12-lead electrocardiography (ECG) examination, chest X-ray and
transthoracic echocardiography. ECG finding collected was largest QRS duration of
the 12 leads. X-ray was used to assess RV lead position<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup>, which was divided into 3 categories: RV apex,
middle RV septum and RV free wall.</p><p>Echocardiography was performed using Vivid E9 machine (GE Healthcare) and EchoPAC
software (GE Healthcare). Single and two-dimensional images were obtained, as were
Doppler velocities and pulsed and continuous Doppler tissue imaging<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup>. All the analyses were performed
after, at least, three months from the date of implantation. The following
measurements of dyssynchrony and ventricular function were analyzed<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup>:</p><p>
<list list-type="bullet"><list-item><p>Driving delay between the interventricular septum and posterior wall in M
mode (cutoff &#x02265; 130 ms);</p></list-item><list-item><p>Difference between pre-ejection times the for the left and right
ventricles (interventricular delay) and the pulsed Doppler (cutoff
&#x02265; 40 ms);</p></list-item><list-item><p>Measure the pre-ejection time LV (aortic) the pulsed Doppler (cutoff
&#x02265; 140 ms);</p></list-item><list-item><p>Measurements of systolic and diastolic left ventricular volume and left
atrial volume in the biplane method;</p></list-item><list-item><p>Left ventricular ejection fraction calculation using the Simpson biplane
method;</p></list-item><list-item><p>Ratio E/e ' by Doppler analysis of transmitral and pulsed Doppler
flow.</p></list-item></list>
</p><sec><title>Statistical Analysis</title><p>The collected data were stored in Excel spreadsheets and analyzed using the
softwares SPSS version 23.0 (IBM Corp. Released 2013. IBM SPSS Statistics for
Windows, Version 22.0. Armonk, NY: IBM Corp.) and MedCalc version 8.2 (MedCalc
Software bvba, Ostend, Belgium; <ext-link ext-link-type="uri" xlink:href="https://www.medcalc.org">https://www.medcalc.org</ext-link>;
2008). Continuous variables were expressed as mean and standard deviation or
median and interquartile range. Categorical variables were presented as absolute
and percentage number.</p><p>Bivariate comparisons were made with chi-square test or test-T-tailed, as
appropriate.</p><p>For correlation analysis between the QRS length and CARE-HF echocardiographic
indexes the Spearman coefficient (rs) was used. The data were transformed into
rank to analyze the differences between the obtained values and the standard
error. A <italic>P</italic>&#x0003c;0.05 was considered statistically
significant.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>A total of 40 patients were included for this analysis. Other two patients able to
participate were excluded because they did not have a post-implant chest X-ray
recorded on our electronic chart. The majority (55%) of patients were male and their
mean age was 69 years (<xref ref-type="table" rid="t1">Table 1</xref>). The most
common pacemaker indication was complete AV block (62.5%). Hypertension was the most
prevalent comorbidity and only 12.5% of patients had mild HF symptoms (NYHA
functional class II). No patient had post procedure cerebrovascular event. Mean
heart rate was 71 beats per minute and mean largest QRS on ECG was
148.97&#x000b1;15.52 ms. Mean RV pacing percentage was 94.95% and most pacemakers
(72.5%) were on DDD mode.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Clinical and pacing echocardiographic characteristics (n=40).</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Variables</th><th align="center" rowspan="1" colspan="1">N (%) or mean &#x000b1; SD</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age</td><td align="center" rowspan="1" colspan="1">69.25&#x000b1;14.76 years</td></tr><tr><td align="left" rowspan="1" colspan="1">Male</td><td align="center" rowspan="1" colspan="1">22 (55%)</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI</td><td align="center" rowspan="1" colspan="1">27.91&#x000b1;4.78</td></tr><tr><td align="left" rowspan="1" colspan="1">Heart rate (bpm)</td><td align="center" rowspan="1" colspan="1">71.15&#x000b1;9.78</td></tr><tr><td align="left" rowspan="1" colspan="1">QRS in lead DII during echo (ms)</td><td align="center" rowspan="1" colspan="1">93.68&#x000b1;15.72</td></tr><tr><td align="left" rowspan="1" colspan="1">Largest QRS on 12 lead ECG</td><td align="center" rowspan="1" colspan="1">148.97&#x000b1;15.52</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypertension</td><td align="center" rowspan="1" colspan="1">26 (65%)</td></tr><tr><td align="left" rowspan="1" colspan="1">DM</td><td align="center" rowspan="1" colspan="1">10 (25%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Dyslipidemia</td><td align="center" rowspan="1" colspan="1">13 (32%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Smoking</td><td align="center" rowspan="1" colspan="1">13 (32.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">CAD</td><td align="center" rowspan="1" colspan="1">6 (15%)</td></tr><tr><td align="left" rowspan="1" colspan="1">NYHA functional class</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;I</td><td align="center" rowspan="1" colspan="1">87.5%</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;II</td><td align="center" rowspan="1" colspan="1">12.5%</td></tr><tr><td align="left" rowspan="1" colspan="1">Current medications</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Diuretics</td><td align="center" rowspan="1" colspan="1">15 (37.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;ACE inhibitors</td><td align="center" rowspan="1" colspan="1">12 (30%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Angiotensin receptor blockers</td><td align="center" rowspan="1" colspan="1">11 (27.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Beta-blockers</td><td align="center" rowspan="1" colspan="1">20 (50%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Calcium channel blockers</td><td align="center" rowspan="1" colspan="1">5 (12.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Amiodarone</td><td align="center" rowspan="1" colspan="1">1 (2.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Reason for the Implant</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Complete AV block</td><td align="center" rowspan="1" colspan="1">25 (62.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;2<sup>nd</sup> degree AV block</td><td align="center" rowspan="1" colspan="1">7 (17.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Others</td><td align="center" rowspan="1" colspan="1">8 (20%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Stimulation Mode</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;DDD</td><td align="center" rowspan="1" colspan="1">29 (72.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;DDDR</td><td align="center" rowspan="1" colspan="1">6 (15%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;VVIR</td><td align="center" rowspan="1" colspan="1">4 (10%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;VDD</td><td align="center" rowspan="1" colspan="1">1 (2.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;RV pacing (%)</td><td align="center" rowspan="1" colspan="1">94.95%&#x000b1;10.65%</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>Bpm=beats per minute; ms=milliseconds; DM=diabetes mellitus; CAD=coronary
artery disease; NYHA=New York Heart Association;
ECG=electrocardiography; ACE=angiotensin enzyme converter, BMI= body
mass index; AV=atrioventricular; RV=right ventricle</p></fn></table-wrap-foot></table-wrap><p>Regarding echocardiographic evaluation, a mean LVEF of 63% was found. QRS measurement
during echocardiogram ranged from 77.96 to 109.4 ms, averaging 93.68 ms on lead DII.
As for dyssynchrony parameters, the pre-aortic ejection time was slightly prolonged
with a mean of 141 ms, and the interventricular delay measurement was also extended,
averaging 43 ms (<xref ref-type="table" rid="t2">Table 2</xref>).</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Echocardiographic measurements of ventricular synchrony, in milliseconds.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Ventricular Synchrony Measurements</th><th align="center" rowspan="1" colspan="1">Mean &#x000b1; SD</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Aortic pre-ejection time</td><td align="center" rowspan="1" colspan="1">140.60&#x000b1;22.52</td></tr><tr><td align="left" rowspan="1" colspan="1">Pulmonary pre-ejection time</td><td align="center" rowspan="1" colspan="1">98.33&#x000b1;22.12</td></tr><tr><td align="left" rowspan="1" colspan="1">Interventricular delay</td><td align="center" rowspan="1" colspan="1">43.27&#x000b1;20.25</td></tr><tr><td align="left" rowspan="1" colspan="1">Septum/posterior wall delay (M mode)</td><td align="center" rowspan="1" colspan="1">105.50&#x000b1;46.9</td></tr><tr><td align="left" rowspan="1" colspan="1">Diastolic volume of LV (ml)</td><td align="center" rowspan="1" colspan="1">91.68&#x000b1;29.08</td></tr><tr><td align="left" rowspan="1" colspan="1">Systolic volume of LV (ml)</td><td align="center" rowspan="1" colspan="1">34&#x000b1;13.10</td></tr><tr><td align="left" rowspan="1" colspan="1">Ejection fraction (%)</td><td align="center" rowspan="1" colspan="1">63.50&#x000b1;6.09</td></tr><tr><td align="left" rowspan="1" colspan="1">Left atrial volume (ml)</td><td align="center" rowspan="1" colspan="1">32.12 &#x000b1;10.24</td></tr><tr><td align="left" rowspan="1" colspan="1">Ratio E/e'</td><td align="center" rowspan="1" colspan="1">11.11&#x000b1;4.50</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p>LV=left ventricle</p></fn></table-wrap-foot></table-wrap><sec><title>Pacing Site Comparisons</title><p>Apical RV lead position was found in 52% of patients, RV medium septum (RVMS) in
42% and RV free wall (RVFW) in the remaining 6%. No differences in QRS duration
between the 3 groups could be noted (<xref ref-type="fig" rid="f1">Figures
1</xref> and <xref ref-type="fig" rid="f2">2</xref>). Mean QRS duration had
a weak correlation with pre-aortic ejection time (r=0:32;
<italic>P</italic>=0.044) (<xref ref-type="fig" rid="f3">Figure 3</xref>) and
had no correlation with interventricular delay (<xref ref-type="fig" rid="f4">Figure 4</xref>). NYHA average was lower in patients with apical
stimulation <italic>(P</italic>&#x0003c;0.001) (<xref ref-type="fig" rid="f5">Figure
5</xref>). Intraventricular delay was lower in those with apical RV pacing
when compared to those with RVMS pacing (34.4&#x000b1;17.2 ms
<italic>vs.</italic> 54.3&#x000b1;19.1 ms; <italic>P</italic>&#x0003c;0.05), and
no difference was found when compared to those with RVFW pacing (<xref ref-type="fig" rid="f6">Figure 6</xref>). Pre-aortic ejection time did not
differ among the groups (<italic>P</italic>=0.9) (<xref ref-type="fig" rid="f7">Figure 7</xref>).</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>QRS on lead DII during echocardiogram (ms).</p><p>RVFW=Right ventricle free wall; RVMS=Right ventricle medium
septum</p></caption><graphic xlink:href="rbccv-32-06-0492-g01"/></fig>
</p><p>
<fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Largest QRS on 12 lead ECG (ms).</p><p>RVFW=right ventricle free wall; RVMS=right ventricle medium
septum</p></caption><graphic xlink:href="rbccv-32-06-0492-g02"/></fig>
</p><p>
<fig id="f3" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>QRS duration and aortic pre-ejection time.</p></caption><graphic xlink:href="rbccv-32-06-0492-g03"/></fig>
</p><p>
<fig id="f4" orientation="portrait" position="float"><label>Fig. 4</label><caption><p>QRS duration and interventricular delay.</p></caption><graphic xlink:href="rbccv-32-06-0492-g04"/></fig>
</p><p>
<fig id="f5" orientation="portrait" position="float"><label>Fig. 5</label><caption><p>New York Heart Association class and lead position.</p><p>NYHA=New York Heart Association; RVFW=right ventricle free wall;
RVMS=right ventricle medium septum</p></caption><graphic xlink:href="rbccv-32-06-0492-g05"/></fig>
</p><p>
<fig id="f6" orientation="portrait" position="float"><label>Fig. 6</label><caption><p>Intraventricular delay and lead position.</p><p>IV=interventricular; RVFW=right ventricle free wall; RVMS=right
ventricle medium septum</p></caption><graphic xlink:href="rbccv-32-06-0492-g06"/></fig>
</p><p>
<fig id="f7" orientation="portrait" position="float"><label>Fig. 7</label><caption><p>Aortic pre-ejection time and pulmonary pre-ejection time according to
pacing site.</p></caption><graphic xlink:href="rbccv-32-06-0492-g07"/></fig>
</p></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>In this study, left ventricular function and myocardial synchrony were compared among
different right ventricular pacing sites. Our main finding was that RV apical pacing
was related to a lower degree of interventricular dyssynchrony when compared to
septal pacing (<xref ref-type="fig" rid="f8">Figure 8</xref>). Furthermore, we found
that QRS duration did not correlate with pacing site and correlated poorly with
dyssynchrony parameters.</p><p>
<fig id="f8" orientation="portrait" position="float"><label>Fig. 8</label><caption><p>Interventricular dyssynchrony and pacing position.</p></caption><graphic xlink:href="rbccv-32-06-0492-g08"/></fig>
</p><p>Our findings are in contrast with several previous studies that have suggested that
RVMS might provide better results when compared to RVA pacing<sup>[<xref rid="r20" ref-type="bibr">20</xref>-<xref rid="r23" ref-type="bibr">23</xref>]</sup>. It has been shown that apical pacing potentially leads to
electrical dyssynchrony, and that it changes the physiological apex-to-base
contraction to an alternate pattern<sup>[<xref rid="r24" ref-type="bibr">24</xref>]</sup>. Theoretically, RVMS pacing could create a faster
depolarization wavefront, since it is in close proximity with the normal conduction
system. However, there are still no conclusive data to prove that these changes
translate into clinical outcomes<sup>[<xref rid="r25" ref-type="bibr">25</xref>]</sup>.</p><p>One of such studies showed that septal pacing not only did not correlate with LVEF
worsening, but also had fewer atrial arrhythmias during the follow-up
period<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup>. It should be
noted, however, that those patients had a lower percentage of RV pacing when
compared to subjects in our study (50-60% <italic>vs.</italic> &#x0003e; 80%). A second
study has shown that septal pacing relates to improvement in 6-minute walk
test<sup>[<xref rid="r23" ref-type="bibr">23</xref>]</sup>, even though the
apical position presented the same result. On the other hand, another study in
elderly patients has shown that even though apical pacing was related with worsening
of LVEF, this finding did not translate into heart failure symptoms<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>. Recent review suggests that
unfavorable clinical outcomes are associated not only with the stimulation site, but
also with other pre-existing condition as CAD and systolic dysfunction where the
compensatory mechanisms of dyssynchrony has been exhausted<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup>.</p><p>The heterogeneity both of dyssynchrony criteria and of patient selection across these
studies interferes with extrapolations and hampers pooled-data analysis. In fact, a
metaanalysis on this subject has highlighted the diversity of study populations and
inclusion criteria concluding that non-apical pacing sites were non-inferior to
apical ones, with a statistical tendency to be better<sup>[<xref rid="r14" ref-type="bibr">14</xref>]</sup>. In this review, 14 randomized clinical trial
analyzed population ranging from 12 to 122 people, followup periods of 3 to 90
months, different evaluation methods (echocardiography and nuclear imaging) and
different cutoff points for ventricular function as selection criteria; some of them
had LVEF as low as 27%. Inclusion of patients with AF and very broad definitions
among the control and study groups by percentage of stimulation below and above 10%,
respectively, contribute even more to the heterogeneity of the results, whose
clinical translation is still uncertain.</p><p>Not evaluating RV outflow tract (RVOT) pacing is a potential limitation of our study.
Even though there are several studies that have suggested this pacing site as a good
alternative to RVA, our institution does not place leads in that position routinely.
Intraventricular flow was not evaluated either, which has been shown to markedly
change in RVA pacing. However, since the clinical meaning of such measurement is yet
unknown, CARE-HF dyssynchrony criteria was chosen to be used in our study, hopefully
to allow study comparisons and pooled-data analysis.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>In this study, RVA pacing showed a lower interventricular conduction delay when
compared to RVMS pacing. Our findings suggest that RVA pacing dyssynchrony is not
ubiquitous as previously thought, and that it should remain an option for lead
placement.</p><table-wrap id="t4" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">APSO</td><td align="left" rowspan="1" colspan="1">Actively participated of literature review, article
review, interpretation of results and approved the final version;
performed the echocardiographic evaluation; final approval of the
version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">SWN</td><td align="left" rowspan="1" colspan="1">Actively participated of literature review, article
review, interpretation of results and approved the final version;
final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">ALGL</td><td align="left" rowspan="1" colspan="1">Actively participated of literature review, article
review, interpretation of results and approved the final version;
final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">MHM</td><td align="left" rowspan="1" colspan="1">Actively participated of literature review, article
review, interpretation of results and approved the final version;
final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">LLGL</td><td align="left" rowspan="1" colspan="1">Actively participated of literature review, article
review, interpretation of results and approved the final version;
final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">EDA</td><td align="left" rowspan="1" colspan="1">Actively participated of literature review, article
review, interpretation of results and approved the final version;
final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">RTS</td><td align="left" rowspan="1" colspan="1">Acquisition, analysis, or interpretation of data for
the work; final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">TLLL</td><td align="left" rowspan="1" colspan="1">Acquisition, analysis, or interpretation of data for
the work; final approval of the version to be published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn><fn fn-type="other"><p>This study was carried out at Instituto de Cardiologia do Rio Grande do
Sul/Funda&#x000e7;&#x000e3;o Universit&#x000e1;ria de Cardiologia, Porto Alegre,
RS, Brazil.</p></fn><fn fn-type="financial-disclosure"><p>No financial support.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furman</surname><given-names>S</given-names></name><name><surname>Schwedel</surname><given-names>JB</given-names></name></person-group><article-title>An intracardiac pacemaker for Stokes-Adams
seizures</article-title><source>N Engl J Med</source><year>1959</year><volume>261</volume><fpage>943</fpage><lpage>948</lpage><pub-id pub-id-type="pmid">13825713</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>HX</given-names></name><name><surname>Qian</surname><given-names>J</given-names></name><name><surname>Hou</surname><given-names>FQ</given-names></name><name><surname>Liu</surname><given-names>YN</given-names></name><name><surname>Mao</surname><given-names>JH</given-names></name></person-group><article-title>Comparison of right ventricular apex and right ventricular
outflow tract septum pacing in the elderly with normal left ventricular
ejection fraction: long-term follow-up</article-title><source>Kardiol Pol</source><year>2012</year><volume>70</volume><issue>11</issue><fpage>1130</fpage><lpage>1139</lpage><pub-id pub-id-type="pmid">23180520</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewicka-Nowak</surname><given-names>E</given-names></name><name><surname>D&#x00105;browska-Kugacka</surname><given-names>A</given-names></name><name><surname>Tybura</surname><given-names>S</given-names></name><name><surname>Krzymi&#x00144;ska-Stasiuk</surname><given-names>E</given-names></name><name><surname>Wilczek</surname><given-names>R</given-names></name><name><surname>Staniewicz</surname><given-names>J</given-names></name><etal/></person-group><article-title>Right ventricular apex versus right ventricular outflow tract
pacing: prospective, randomised, long-term clinical and echocardiographic
evaluation</article-title><source>Kardiol Pol</source><year>2006</year><volume>64</volume><issue>10</issue><fpage>1082</fpage><lpage>1091</lpage><pub-id pub-id-type="pmid">17089240</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markuszewski</surname><given-names>L</given-names></name><name><surname>Rosiak</surname><given-names>M</given-names></name><name><surname>Grycewicz</surname><given-names>T</given-names></name><name><surname>Micha&#x00142;kiewicz</surname><given-names>D</given-names></name><name><surname>Cwetsch</surname><given-names>A</given-names></name><name><surname>Chudzik</surname><given-names>M</given-names></name></person-group><article-title>Right ventricle pacing site optimization guided by intracardiac
echocardiography</article-title><source>Pol Merkur Lekarski</source><year>2006</year><volume>21</volume><issue>124</issue><fpage>314</fpage><lpage>318</lpage><pub-id pub-id-type="pmid">17205767</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrari</surname><given-names>AD</given-names></name><name><surname>Borges</surname><given-names>AP</given-names></name><name><surname>Albuquerque</surname><given-names>LC</given-names></name><name><surname>Pelzer Sussenbach</surname><given-names>C</given-names></name><name><surname>Rosa</surname><given-names>PR</given-names></name><name><surname>Piant&#x000e1;</surname><given-names>RM</given-names></name><etal/></person-group><article-title>Cardiomyopathy induced by artificial cardiac pacing: myth or
reality sustained by evidence?</article-title><source>Rev Bras Cir Cardiovasc</source><year>2014</year><volume>29</volume><issue>3</issue><fpage>402</fpage><lpage>413</lpage><pub-id pub-id-type="pmid">25372916</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simantirakis</surname><given-names>EN</given-names></name><name><surname>Prassopoulos</surname><given-names>VK</given-names></name><name><surname>Chrysostomakis</surname><given-names>SI</given-names></name><name><surname>Kochiadakis</surname><given-names>GE</given-names></name><name><surname>Koukouraki</surname><given-names>SI</given-names></name><name><surname>Lekakis</surname><given-names>JP</given-names></name><etal/></person-group><article-title>Effects of asynchronous ventricular activation on myocardial
adrenergic innervation in patients with permanent dual-chamber pacemakers;
an I(123)-metaiodobenzylguanidine cardiac scintigraphic
study</article-title><source>Eur Heart J</source><year>2001</year><volume>22</volume><issue>4</issue><fpage>323</fpage><lpage>332</lpage><pub-id pub-id-type="pmid">11161951</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sweeney</surname><given-names>MO</given-names></name><name><surname>Hellkamp</surname><given-names>AS</given-names></name><name><surname>Ellenbogen</surname><given-names>KA</given-names></name><name><surname>Greenspon</surname><given-names>AJ</given-names></name><name><surname>Freedman</surname><given-names>RA</given-names></name><name><surname>Lee</surname><given-names>KL</given-names></name><etal/></person-group><article-title>Adverse effect of ventricular pacing on heart failure and atrial
fibrillation among patients with normal baseline QRS duration in a clinical
trial of pacemaker therapy for sinus node dysfunction</article-title><source>Circulation</source><year>2003</year><volume>107</volume><issue>23</issue><fpage>2932</fpage><lpage>2937</lpage><pub-id pub-id-type="pmid">12782566</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thambo</surname><given-names>JB</given-names></name><name><surname>Bordachar</surname><given-names>P</given-names></name><name><surname>Garrigue</surname><given-names>S</given-names></name><name><surname>Lafitte</surname><given-names>S</given-names></name><name><surname>Sanders</surname><given-names>P</given-names></name><name><surname>Reuter</surname><given-names>S</given-names></name><etal/></person-group><article-title>Detrimental ventricular remodeling in patients with congenital
complete heart block and chronic right ventricular apical
pacing</article-title><source>Circulation</source><year>2004</year><volume>110</volume><issue>25</issue><fpage>3766</fpage><lpage>3772</lpage><pub-id pub-id-type="pmid">15583083</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>XH</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Siu</surname><given-names>CW</given-names></name><name><surname>Yiu</surname><given-names>KH</given-names></name><name><surname>Chan</surname><given-names>WS</given-names></name><name><surname>Lee</surname><given-names>KL</given-names></name><etal/></person-group><article-title>New-onset heart failure after permanent right ventricular apical
pacing in patients with acquired high-grade atrioventricular block and
normal left ventricular function</article-title><source>J Cardiovasc Electrophysiol</source><year>2008</year><volume>19</volume><issue>2</issue><fpage>136</fpage><lpage>141</lpage><pub-id pub-id-type="pmid">18005026</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Jiang</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name></person-group><article-title>Comparison of effectiveness of right ventricular mid-septal
pacing vs. apical pacing: a randomized-controlled trials</article-title><source>Eur Heart J Suppl</source><year>2016</year><volume>18</volume><issue>Suppl F</issue><fpage>F12</fpage><lpage>F18</lpage><pub-id pub-id-type="pmid">28533725</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname><given-names>C</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>C</given-names></name><etal/></person-group><article-title>Right ventricular outflow tract septal pacing is superior to
right ventricular apical pacing</article-title><source>J Am Heart Assoc</source><year>2015</year><volume>4</volume><issue>4</issue><elocation-id>e001777</elocation-id><pub-id pub-id-type="pmid">25896891</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkoff</surname><given-names>BL</given-names></name><name><surname>Cook</surname><given-names>JR</given-names></name><name><surname>Epstein</surname><given-names>AE</given-names></name><name><surname>Greene</surname><given-names>HL</given-names></name><name><surname>Hallstrom</surname><given-names>AP</given-names></name><name><surname>Hsia</surname><given-names>H</given-names></name><etal/></person-group><article-title>Dual-chamber pacing or ventricular backup pacing in patients with
an implantable defibrillator: the Dual Chamber and VVI Implantable
Defibrillator (DAVID) trial</article-title><source>JAMA</source><year>2002</year><volume>288</volume><issue>24</issue><fpage>3115</fpage><lpage>3123</lpage><pub-id pub-id-type="pmid">12495391</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curtis</surname><given-names>AB</given-names></name><name><surname>Worley</surname><given-names>SJ</given-names></name><name><surname>Adamson</surname><given-names>PB</given-names></name><name><surname>Chung</surname><given-names>ES</given-names></name><name><surname>Niazi</surname><given-names>I</given-names></name><name><surname>Sherfesee</surname><given-names>L</given-names></name><etal/></person-group><article-title>Biventricular pacing for atrioventricular block and systolic
dysfunction (BLOCK HF) trial</article-title><source>N Engl J Med</source><year>2013</year><volume>368</volume><issue>17</issue><fpage>1585</fpage><lpage>1593</lpage><pub-id pub-id-type="pmid">23614585</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimony</surname><given-names>A</given-names></name><name><surname>Eisenberg</surname><given-names>MJ</given-names></name><name><surname>Filion</surname><given-names>KB</given-names></name><name><surname>Amit</surname><given-names>G</given-names></name></person-group><article-title>Beneficial effects of right ventricular non-apical vs. apical
pacing: a systematic review and meta-analysis of randomized-controlled
trials</article-title><source>Europace</source><year>2012</year><volume>14</volume><issue>1</issue><fpage>81</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">21798880</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cicchitti</surname><given-names>V</given-names></name><name><surname>Radico</surname><given-names>F</given-names></name><name><surname>Bianco</surname><given-names>F</given-names></name><name><surname>Gallina</surname><given-names>S</given-names></name><name><surname>Tonti</surname><given-names>G</given-names></name><name><surname>De Caterina</surname><given-names>R</given-names></name></person-group><article-title>Heart failure due to right ventricular apical pacing: the
importance of flow patterns</article-title><source>Europace</source><year>2016</year><volume>18</volume><issue>11</issue><fpage>1679</fpage><lpage>1688</lpage><pub-id pub-id-type="pmid">27247008</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>GY</given-names></name><name><surname>Kim</surname><given-names>MJ</given-names></name><name><surname>Park</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>HS</given-names></name><name><surname>Youn</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>KH</given-names></name><etal/></person-group><article-title>Comparison of ventricular dyssynchrony according to the position
of right ventricular pacing electrode: a multi-center prospective
echocardiographic study</article-title><source>J Cardiovasc Ultrasound</source><year>2011</year><volume>19</volume><issue>1</issue><fpage>15</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">21519487</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cleland</surname><given-names>JG</given-names></name><name><surname>Daubert</surname><given-names>JC</given-names></name><name><surname>Erdmann</surname><given-names>E</given-names></name><name><surname>Freemantle</surname><given-names>N</given-names></name><name><surname>Gras</surname><given-names>D</given-names></name><name><surname>Kappenberger</surname><given-names>L</given-names></name><etal/></person-group><article-title>The CARE-HF study (Cardiac Resynchronisation in Heart Failure
study): rationale, design and end-points</article-title><source>Eur J Heart Fail</source><year>2001</year><volume>3</volume><issue>4</issue><fpage>481</fpage><lpage>489</lpage><pub-id pub-id-type="pmid">11511435</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Th&#x000e9;bault</surname><given-names>C</given-names></name><name><surname>Donal</surname><given-names>E</given-names></name><name><surname>Meunier</surname><given-names>C</given-names></name><name><surname>Gervais</surname><given-names>R</given-names></name><name><surname>Gerritse</surname><given-names>B</given-names></name><name><surname>Gold</surname><given-names>MR</given-names></name><etal/></person-group><article-title>Sites of left and right ventricular lead implantation and
response to cardiac resynchronization therapy observations from the REVERSE
trial</article-title><source>Eur Heart J</source><year>2012</year><volume>33</volume><issue>21</issue><fpage>2662</fpage><lpage>2671</lpage><pub-id pub-id-type="pmid">22285578</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benfatti</surname><given-names>RA</given-names></name><name><surname>Manzano</surname><given-names>FM</given-names></name><name><surname>Pontes</surname><given-names>JC</given-names></name><name><surname>Dias</surname><given-names>AE</given-names></name><name><surname>Duarte</surname><given-names>JJ</given-names></name><name><surname>Silva</surname><given-names>GV</given-names></name><etal/></person-group><article-title>Analysis of left ventricular function in patients with heart
failure undergoing cardiac resynchronization</article-title><source>Rev Bras Cir Cardiovasc</source><year>2013</year><volume>28</volume><issue>1</issue><fpage>69</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">23739935</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yusu</surname><given-names>S</given-names></name><name><surname>Mera</surname><given-names>H</given-names></name><name><surname>Hoshida</surname><given-names>K</given-names></name><name><surname>Miyakoshi</surname><given-names>M</given-names></name><name><surname>Miwa</surname><given-names>Y</given-names></name><name><surname>Tsukada</surname><given-names>T</given-names></name><etal/></person-group><article-title>Selective site pacing from the right ventricular mid-septum.
Follow-up of lead performance and procedure technique</article-title><source>Int Heart J</source><year>2012</year><volume>53</volume><issue>2</issue><fpage>113</fpage><lpage>116</lpage><pub-id pub-id-type="pmid">22688315</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kikuchi</surname><given-names>M</given-names></name><name><surname>Tanno</surname><given-names>K</given-names></name><name><surname>Miyoshi</surname><given-names>F</given-names></name><name><surname>Munetsugu</surname><given-names>Y</given-names></name><name><surname>Onuma</surname><given-names>Y</given-names></name><name><surname>Ito</surname><given-names>H</given-names></name><etal/></person-group><article-title>Long-term effectiveness of right septal pacing vs. right apical
pacing in patients with atrioventricular block</article-title><source>J Arrhythmia</source><year>2012</year><volume>28</volume><issue>4</issue><fpage>214</fpage><lpage>218</lpage></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Mao</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>SH</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Luo</surname><given-names>QZ</given-names></name><name><surname>Pan</surname><given-names>WQ</given-names></name><etal/></person-group><article-title>Is right ventricular mid-septal pacing superior to apical pacing
in patients with high degree atrio-ventricular block and moderately
depressed left ventricular function?</article-title><source>J Zhejiang Univ Sci B</source><year>2014</year><volume>15</volume><issue>6</issue><fpage>507</fpage><lpage>514</lpage><pub-id pub-id-type="pmid">24903987</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molina</surname><given-names>L</given-names></name><name><surname>Sutton</surname><given-names>R</given-names></name><name><surname>Gandoy</surname><given-names>W</given-names></name><name><surname>Reyes</surname><given-names>N</given-names></name><name><surname>Lara</surname><given-names>S</given-names></name><name><surname>Lim&#x000f3;n</surname><given-names>F</given-names></name><etal/></person-group><article-title>Medium-term effects of septal and apical pacing in
pacemaker-dependent patients: a double-blind prospective randomized
study</article-title><source>Pacing Clin Electrophysiol</source><year>2014</year><volume>37</volume><issue>2</issue><fpage>207</fpage><lpage>214</lpage><pub-id pub-id-type="pmid">23998710</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freudenberger</surname><given-names>RS</given-names></name><name><surname>Wilson</surname><given-names>AC</given-names></name><name><surname>Lawrence-Nelson</surname><given-names>J</given-names></name><name><surname>Hare</surname><given-names>JM</given-names></name><name><surname>Kostis</surname><given-names>JB</given-names></name><collab>Myocardial Infarction Data Acquisition System Study Group (MIDAS
9)</collab></person-group><article-title>Permanent pacing is a risk factor for the development of heart
failure</article-title><source>Am J Cardiol</source><year>2005</year><volume>95</volume><issue>5</issue><fpage>671</fpage><lpage>674</lpage><pub-id pub-id-type="pmid">15721119</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaye</surname><given-names>GC</given-names></name><name><surname>Linker</surname><given-names>NJ</given-names></name><name><surname>Marwick</surname><given-names>TH</given-names></name><name><surname>Pollock</surname><given-names>L</given-names></name><name><surname>Graham</surname><given-names>L</given-names></name><name><surname>Pouliot</surname><given-names>E</given-names></name><etal/></person-group><article-title>Effect of right ventricular pacing lead site on left ventricular
function in patients with high-grade atrioventricular block: results of the
Protect-Pace study</article-title><source>Eur Heart J</source><year>2015</year><volume>36</volume><issue>14</issue><fpage>856</fpage><lpage>862</lpage><pub-id pub-id-type="pmid">25189602</pub-id></element-citation></ref></ref-list></back></article>